Abstract
Dexmedetomidine is a selective alpha2 agonist, which is widely used for conscious sedation in ICU patients. It is being increasingly used to provide conscious sedation in out-of-theatre procedures like CT scan, MRI, endoscopies and catheterization (cath) procedures. There is limited data till date regarding the effect of dexmedetomidine on coronary vessel diameter. The aim of this prospective observational study was to observe the effect of dexmedetomidine on normal coronary vessel diameter. Fifty patients who had come for elective coronary angiography in the cath lab were enrolled in the study. After taking the first shot of the coronary angiogram and confirming that the right coronary artery (RCA) is normal, dexmedetomidine was administered in a dose of 1 µg/kg intravenously over 15 min. Immediately after that, another shot was taken to check the diameter of RCA. Paired Student's t test was used to analyze the data. The mean diameter of RCA before giving dexmedetomidine was 2.7634 ± 0.3189 mm. The mean diameter decreased significantly to 2.6296 ± 0.3379 mm after administration of dexmedetomidine (p value <0.0001). Thus, dexmedetomidine decreases the coronary vessel diameter.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
